<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Clinical Trial Endpoints for the Approval of Non-Small Cell Lung Cancer Drugs and Biologics; Guidance for Industry; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Clinical Trial Endpoints for the Approval of Non-Small Cell Lung Cancer Drugs and Biologics; Guidance for Industry; Availability</h1>
    <p class="timestamp">Published: 2015-04-22 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing the availability of a guidance for industry entitled "Clinical Trial Endpoints for the Approval of Non-Small Cell Lung Cancer Drugs and Biologics." This guidance provides recommendations to applicants on endpoints for cancer clinical trials submitted to FDA to support effectiveness claims in new drug applications, biologics license applications, or supplemental applications for the treatment of non- small cell lung cancer. This guida...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2015-09303</p>
    <p><strong>Publication Date:</strong> 2015-04-22</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2015/04/22/2015-09303/clinical-trial-endpoints-for-the-approval-of-non-small-cell-lung-cancer-drugs-and-biologics-guidance">https://www.federalregister.gov/documents/2015/04/22/2015-09303/clinical-trial-endpoints-for-the-approval-of-non-small-cell-lung-cancer-drugs-and-biologics-guidance</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2015-09303</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
